Disrupting cellular memory to overcome drug resistance
Guillaume Harmange1, Raúl A Reyes Hueros2, Dylan L Schaff3
1Cellular and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Scientists developed a new method to track gene expression memory in single cells. This technique identified PI3K and TGF-β pathways as key regulators, offering new strategies to overcome therapy resistance in melanoma.
Area of Science:
- Cellular biology
- Molecular biology
- Cancer research
Background:
- Gene expression memory, the persistence of gene expression states in single cells, influences cell fate.
- State switching, or loss of gene expression memory, can occur without genetic alterations.
- Current methods for identifying regulators of gene expression memory and tracking state switching are limited.
Purpose of the Study:
- To develop a lineage tracing-based technique for quantifying gene expression memory and identifying state-switching cells.
- To investigate gene expression dynamics in melanoma cells and their link to targeted therapy resistance.
- To identify modulators of gene expression memory and cell fate in melanoma.
Main Methods:
- Development of a novel lineage tracing technique to measure gene expression memory.
- Application of the technique to melanoma cells to quantify memory and identify state-switching dynamics.
- Analysis of gene expression fluctuations predictive of resistance to targeted therapy.
Main Results:
- Quantification of long-lived gene expression fluctuations in untreated melanoma cells.
- Identification of the PI3K and TGF-β pathways as critical modulators of gene expression state switching.
- Demonstration that a pretreatment model involving a PI3K inhibitor followed by targeted therapy reduces therapy resistance.
Conclusions:
- The developed lineage tracing method effectively quantifies gene expression memory and identifies state-switching cells.
- PI3K and TGF-β pathways play significant roles in regulating gene expression memory and cell fate in melanoma.
- A novel pretreatment strategy combining PI3K inhibition with targeted therapy shows promise in overcoming melanoma resistance.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Desensitization and Tachyphylaxis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
